Home Biosimilar Antibodies Angiogenesis EGFR inhibitor Laprituximab emtansine For research use only.
Not for use in humans.

Laprituximab emtansine

Synonyms: IMGN-289

Laprituximab emtansine (IMGN-289) is an anti-EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB), chimeric monoclonal antibody conjugated to maytansinoid DM1 via a succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) linker, forming a nonreducible thioether bond.

Laprituximab emtansine

CAS No. 1622327-37-0

Click to purchase the isotype control of Laprituximab emtansine

Purity & Quality Control

≥99

Choose Selective EGFR Inhibitors

Biological Activity

Description Laprituximab emtansine (IMGN-289) is an anti-EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB), chimeric monoclonal antibody conjugated to maytansinoid DM1 via a succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) linker, forming a nonreducible thioether bond.

Product Details

CAS No. 1622327-37-0
ADC antiody Laprituximab
ADC cytotoxin DM1
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Laprituximab emtansine | Laprituximab emtansine supplier | purchase Laprituximab emtansine | Laprituximab emtansine cost | Laprituximab emtansine manufacturer | order Laprituximab emtansine | Laprituximab emtansine distributor